Interpharm Holdings Quick Ratio 1971-1970 | IPAH

Historical quick ratio values for Interpharm Holdings (IPAH) over the last 10 years.
Interpharm Holdings Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. The Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.128B 6.91
Dr Reddy's Laboratories (RDY) India $12.012B 21.80
BridgeBio Pharma (BBIO) United States $6.407B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.819B 14.76
Bausch Health Cos (BHC) Canada $1.667B 1.23
Amphastar Pharmaceuticals (AMPH) United States $1.155B 7.70
Taysha Gene Therapies (TSHA) United States $0.525B 0.00
Personalis (PSNL) United States $0.432B 0.00
Assembly Biosciences (ASMB) United States $0.095B 0.00
Sol-Gel Technologies (SLGL) Israel $0.021B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00